[1] S.Curtze. D.Strbian. et al. Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use.[J]European Journal of Neurology.2014, 21: 616–622 [2] SR Lentz .Genetic testing to guide warfarin dosing: Impact of direct oral anticoagulants [J]. Clinl Pharmacol Ther.2016.5.00.(00)1-2 [3] Farhad Kamali. Hilary Wynne. Pharmacogenetics of warfarin.[J].Annu. Rev. Med. 2010. 61:63-75 [4] Grossniklaus D.Testing of VKORC1 and CYP2C9 alleles to guide warfarin dosing.[J].Test category: pharmacogenomic (treatment).2010.9 [5] Sconce EA, Khan TI. et al.The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Blood, 2005, 106: 2329~2333. [6] 郑金刚.心血管系统疾病和药物基因组学.科学出版社.2010.4.P541.